Literature DB >> 25172048

Development of an enzyme-linked immunospot assay for determination of rotavirus infectivity.

Tingdong Li1, Haijun Lin2, Linqi Yu1, Miaoge Xue2, Shengxiang Ge3, Qinjian Zhao1, Jun Zhang1, Ningshao Xia4.   

Abstract

Conventional rotavirus infectivity assays are time consuming, labor intensive, and with low sample throughput. To overcome these problems, a 96-well microplate enzyme-linked immunospot assay (Elispot) was developed for the measurement of rotavirus infectious titers. The infected MA104 cells were stained with a horseradish peroxidase-conjugated anti-VP6 monoclonal antibody followed by detection with an ELISPOT analyzer. A linear relationship was found between spot number and input of rotavirus dose in SA11 and 10 rotavirus isolates of different genotypes. The propagation of rotavirus SA11 in MA104 cells was monitored, and the neutralizing activity of serum samples and monoclonal antibodies was determined. The 50% neutralizing titer (NT50) of serum and 50% inhibitory concentration (IC50) of monoclonal antibodies were correlated well with the results determined by ELISA-based neutralization assay. In conclusion, a rapid and semi-automated procedure to determine rotavirus infectivity was developed, which will be useful to study the infectivity and the neutralizing epitopes of rotavirus.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Elispot; Infectivity; Neutralization; Rotavirus

Mesh:

Substances:

Year:  2014        PMID: 25172048     DOI: 10.1016/j.jviromet.2014.08.012

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

1.  Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model.

Authors:  Miaoge Xue; Linqi Yu; Lianzhi Jia; Yijian Li; Yuanjun Zeng; Tingdong Li; Shengxiang Ge; Ningshao Xia
Journal:  Hum Vaccin Immunother       Date:  2016-07-19       Impact factor: 3.452

2.  Baseline antibody level may help predict the risk of active human cytomegalovirus infection in a HCMV seropositive population.

Authors:  T-D Li; J-J Li; X Huang; H Wang; X-Y Guo; S-X Ge; J Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-28       Impact factor: 3.267

Review 3.  An updated view on horseradish peroxidases: recombinant production and biotechnological applications.

Authors:  Florian W Krainer; Anton Glieder
Journal:  Appl Microbiol Biotechnol       Date:  2015-01-11       Impact factor: 4.813

Review 4.  Antibody Engineering for Pursuing a Healthier Future.

Authors:  Abdullah F U H Saeed; Rongzhi Wang; Sumei Ling; Shihua Wang
Journal:  Front Microbiol       Date:  2017-03-28       Impact factor: 5.640

5.  Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses.

Authors:  Guoxing Luo; Yuanjun Zeng; Han Yang; Yijian Li; Lianwei Yang; Cao Li; Feibo Song; Shiyin Zhang; Tingdong Li; Shengxiang Ge; Jun Zhang; Ningshao Xia
Journal:  iScience       Date:  2022-09-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.